Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

BRTX BioRestorative Therapies, Inc. Common Stock (NV)
$1.14 0.00% 0.00
Notify me if price changes either direction
Interactive Brokers Logotype

Buy BRTX stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 10.1M
Enterprise value 5.6M
Trailing PE -0.98275860835766
Forward PE -0.8444444
PEG Ratio -0.0063879309543248
Enterprise to EBITDA -0.394
Enterprise to revenue 14.718
Price to book MRQ 4.1454544
Price to sales TTM 26.392582

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter (MRQ) 2025-09-30
Revenue (TTM) 383.4K
EBITDA -14304456
Diluted EPS TTM -1.47
Total Cash (MRQ) 4.5M
Current ratio (MRQ) 1.37
Operating Cash Flow (TTM) -10721635

BRTX trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent BRTX News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.